Abstract
Purpose
This study was designed to assess the outcomes of subcentimeter thyroid nodules with highly suspicious ultrasonography (US) features and to investigate the predictive factors associated with malignancy and aggressive biological behavior to determine appropriate candidate factors for active surveillance.
Methods
Between June 2011 and December 2013, 1866 subcentimeter thyroid nodules with highly suspicious US features that were subjected to US-guided fine needle aspiration and subsequent surgery or US follow-up of at least 2 years were evaluated. A multivariate logistic regression analysis was performed to identify independent clinical characteristics and US features associated with the malignancy rate and aggressive biological behavior.
Results
Of the 1866 subcentimeter thyroid nodules, 821 (44.0%) were benign and 1045 (56.0%) were malignant. Age younger than 45 years, presence of microcalcification, and a taller than wide shape on US were associated independently with malignancy in the subcentimeter thyroid nodules (P < 0.05). Of 1041 evaluated papillary microcarcinomas, a multivariate analysis revealed that male gender, presence of microcalcification, and a taller than wide on US were independently associated with lymph node metastasis and ATA intermediate risk (P < 0.01).
Conclusions
Age younger than 45 years, male gender, and subcentimeter thyroid nodules exhibiting microcalcification, and a taller than wide shape on US might be not good candidate factors for active surveillance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–7.
Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”–screening and overdiagnosis. N Engl J Med. 2014;371:1765–7.
Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.
Berker D, Aydin Y, Ustun I, et al. The value of fine-needle aspiration biopsy in subcentimeter thyroid nodules. Thyroid. 2008;18:603–8.
Haugen BRM, Alexander EK, Bible KC, et al. American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;26(1):1–133.
Kim JY, Jung EJ, Park T, et al. Impact of tumor size on subclinical central lymph node metastasis in papillary thyroid microcarcinoma depends on age. World J Surg Oncol. 2015;13:88.
Qu N, Zhang L, Ji QH, et al. Risk factors for central compartment lymph node metastasis in papillary thyroid microcarcinoma: a meta-analysis. World J Surg. 2015;39:2459–70.
Clain JB, Scherl S, Dos Reis L, et al. Extrathyroidal extension predicts extranodal extension in patients with positive lymph nodes: an important association that may affect clinical management. Thyroid. 2014;24:951–7.
Soudry E, Hilly O, Preis M, et al. Analysis of the prognostic significance of lymph node related characteristics in papillary thyroid carcinoma patients presenting with pre- or intra-operative evidence of cervical lymph node metastases. J Laryngol Otol. 2014;128:284–8.
Mercante G, Frasoldati A, Pedroni C, et al. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid. 2009;19:707–16.
Usluogullari CA, Onal ED, Ozdemir E, et al. A retrospective analysis of prognostic factors predictive of lymph-node metastasis and recurrence in thyroid papillary microcarcinoma. Minerva Endocrinol. 2015;40:15–22.
Pisanu A, Saba A, Podda M, Reccia I, Uccheddu A. Nodal metastasis and recurrence in papillary thyroid microcarcinoma. Endocrine. 2015;48:575–81.
Cibas ES, Ali SZ. The Bethesda System for reporting thyroid cytopathology. Thyroid. 2009;19:1159–65.
Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13:381–7.
Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34:28–35.
Miyauchi A. Clinical trials of active surveillance of papillary microcarcinoma of the thyroid. World J Surg. 2016;40:516–22.
Brito JP, Ito Y, Miyauchi A, Tuttle RM. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid. 2016;26:144–9.
Roti E, degli Uberti EC, Bondanelli M, Braverman LE. Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol. 2008;159:659–73.
Ito Y, Higashiyama T, Takamura Y, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg. 2007;31:2085–91.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
No conflict of interest in this study.
Rights and permissions
About this article
Cite this article
Gweon, H.M., Son, E.J., Kim, JA. et al. Predictive Factors for Active Surveillance of Subcentimeter Thyroid Nodules with Highly Suspicious US Features. Ann Surg Oncol 24, 1540–1545 (2017). https://doi.org/10.1245/s10434-016-5728-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-016-5728-8